BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 20677995)

  • 1. Sexual dysfunction, depression, and anxiety among patients of an inner-city menopause clinic.
    Schnatz PF; Whitehurst SK; O'Sullivan DM
    J Womens Health (Larchmt); 2010 Oct; 19(10):1843-9. PubMed ID: 20677995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women.
    Sidi H; Puteh SE; Abdullah N; Midin M
    J Sex Med; 2007 Mar; 4(2):311-21. PubMed ID: 17040486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, risk factors, and predictors of female sexual dysfunction in a primary care setting: a survey finding.
    Ishak IH; Low WY; Othman S
    J Sex Med; 2010 Sep; 7(9):3080-7. PubMed ID: 20584130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of sexual dysfunction and urinary incontinence and associated risk factors in Turkish women.
    Çayan S; Yaman Ö; Orhan İ; Usta M; Başar M; Resim S; Aşcı R; Gümüş B; Kadıoğlu A
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():303-8. PubMed ID: 27423031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?
    Hayes RD; Dennerstein L; Bennett CM; Fairley CK
    J Sex Med; 2008 Apr; 5(4):777-787. PubMed ID: 18266650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopause and sexuality: prevalence of symptoms and impact on quality of life.
    Nappi RE; Lachowsky M
    Maturitas; 2009 Jun; 63(2):138-41. PubMed ID: 19464129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Espinoza MT; Flores D; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Vallejo S; Tserotas K;
    Menopause; 2009; 16(6):1139-48. PubMed ID: 19458559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conceptualizing women's sexual function: linear vs. circular models of sexual response.
    Giles KR; McCabe MP
    J Sex Med; 2009 Oct; 6(10):2761-71. PubMed ID: 19686428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and risk factors of female sexual dysfunction in young korean women: an internet-based survey.
    Song SH; Jeon H; Kim SW; Paick JS; Son H
    J Sex Med; 2008 Jul; 5(7):1694-701. PubMed ID: 18422495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexuality and quality of life in women with a prior diagnosis of breast cancer after risk-reducing salpingo-oophorectomy.
    Tucker PE; Saunders C; Bulsara MK; Tan JJ; Salfinger SG; Green H; Cohen PA
    Breast; 2016 Dec; 30():26-31. PubMed ID: 27592287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India.
    Singh JC; Tharyan P; Kekre NS; Singh G; Gopalakrishnan G
    J Postgrad Med; 2009; 55(2):113-20. PubMed ID: 19550056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction.
    Maseroli E; Fanni E; Fambrini M; Ragghianti B; Limoncin E; Mannucci E; Maggi M; Vignozzi L
    J Endocrinol Invest; 2016 Apr; 39(4):401-9. PubMed ID: 26335300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and evaluation of sexual health problems--HSDD in Europe.
    Graziottin A
    J Sex Med; 2007 Mar; 4 Suppl 3():211-9. PubMed ID: 17394593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent and lifelong sexual dysfunction in a female UK population sample: prevalence and risk factors.
    Burri A; Spector T
    J Sex Med; 2011 Sep; 8(9):2420-30. PubMed ID: 21676186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From whence comes HSDD?
    Parish SJ
    J Fam Pract; 2009 Jul; 58(7 Suppl Hypoactive):S16-21. PubMed ID: 19825314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors.
    Safarinejad MR
    Int J Impot Res; 2006; 18(4):382-95. PubMed ID: 16395324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 10-year interval study to compare the prevalence and risk factors of female sexual dysfunction in Korea: the Korean internet sexuality survey (KISS) 2014.
    Shin H; Min B; Park J; Son H
    Int J Impot Res; 2017 Mar; 29(2):49-53. PubMed ID: 27928152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome.
    Martelli V; Valisella S; Moscatiello S; Matteucci C; Lantadilla C; Costantino A; Pelusi G; Marchesini G; Meriggiola MC
    J Sex Med; 2012 Feb; 9(2):434-41. PubMed ID: 22023878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual activity and function in middle-aged and older women.
    Addis IB; Van Den Eeden SK; Wassel-Fyr CL; Vittinghoff E; Brown JS; Thom DH;
    Obstet Gynecol; 2006 Apr; 107(4):755-64. PubMed ID: 16582109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors of the female sexual dysfunction in a sample of infertile Iranian women.
    Pakpour AH; Yekaninejad MS; Zeidi IM; Burri A
    Arch Gynecol Obstet; 2012 Dec; 286(6):1589-96. PubMed ID: 22850887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.